Secukinumab for Treatment of Atopic Dermatitis
Clinical trial NCT02594098 · COMPLETED
Trial details
- NCT number
- NCT02594098
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-01-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.